Prostate Cancer Survivors Present Long-Term, Residual Systemic Immune Alterations

Prostate Cancer Survivors Present Long-Term, Residual Systemic Immune Alterations

Background: The development of cancer and anti-tumor therapies can lead to systemic immune alterations but little is known about how long immune dysfunction persists in cancer survivors. Methods: We followed changes in the cellular immune parameters of prostate cancer patients with good prognostic c...

Full description

Bibliographic Details
Main Authors: Katalin Balázs, Zsuzsa S. Kocsis, Péter Ágoston, Kliton Jorgo, László Gesztesi, Gyöngyi Farkas, Gábor Székely, Zoltán Takácsi-Nagy, Csaba Polgár, Géza Sáfrány, Zsolt Jurányi, Katalin Lumniczky
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Cancers
Subjects:
prostate cancer
radiotherapy
immune phenotyping
adaptive immune response
innate immune response
Online Access:https://www.mdpi.com/2072-6694/14/13/3058

Internet

https://www.mdpi.com/2072-6694/14/13/3058

Similar Items